News + Filings Transactions Holdings
|
ARCH Venture Fund VIII, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/13/2022 | Codiak BioSciences, Inc. | CDAK | Purchase | Warrant (Right to Buy) | 5M | $1.88 | $9.4M | | 09/13/2022 |
| 09/13/2022 | Codiak BioSciences, Inc. | CDAK | Purchase | Common Sotck | 5M | $1.50 | $7.5M | See footnotes | 09/13/2022 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 1.8M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 831.5k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 420.4k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 327k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 191.7k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Purchase | Common Stock | 235k | $15.00 | $3.5M | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series A Preferred Stock | 14M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series A Preferred Stock | 6.5M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series B Preferred Stock | 3M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series B Preferred Stock | 2.3M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series C Preferred Stock | 1.3M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common Stock | 2M | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common Stock | 472.3k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common Stock | 138.7k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Purchase | Common Stock | 210k | $13.00 | $2.7M | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common Stock | 138.7k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Purchase | Common Stock | 20k | $13.00 | $260k | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series A Convertible Preferred Stock | 2M | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series B Convertible Preferred Stock | 472.3k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series C Convertible Preferred Stock | 138.7k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series C Convertible Preferred Stock | 138.7k | $0.00 | $0 | See footnote | 09/18/2020 |
| 08/08/2019 | Denali Therapeutics Inc. | DNLI | Other (disposition) | Common Stock | 400k | $0.00 | $0 | | 08/08/2019 |
| 05/21/2019 | Homology Medicines, Inc. | FIXX | Other (disposition) | Common Stock | 300k | $0.00 | $0 | | 05/21/2019 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Common Stock | 437.9k | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Common Stock | 634.6k | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Common Stock | 551.8k | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Common Stock | 719.6k | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Common Stock | 293.8k | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Series A-2 Preferred | 1.2M | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Series A-3 Preferred | 1.8M | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Series A-4 Preferred | 1.6M | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Series B Preferred | 2.1M | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
| 05/29/2018 | Scholar Rock Holding Corp | SRRK | Conversion | Series C Preferred | 838.8k | $0.00 | $0 | By ARCH Venture Fund VIII, L.P. | 05/29/2018 |
|
|